Form DEF 14A PACIFIC BIOSCIENCES OF For: Jun 18
http://archive.fast-edgar.com/20240429/A4ZZT22CZ22RG2B2222F22Z2NLG3ZZ2S4962
Filed on: April 29, 2024
Form 8-K Sight Sciences, Inc. For: Apr 26
http://archive.fast-edgar.com/20240429/AQ2ZM22DZM2RV2Z2222R2CYOI5GDZZ223S62
Filed on: April 29, 2024
Form 6-K Electrovaya Inc. For: Apr 29
http://archive.fast-edgar.com/20240429/A9BEB22CZ222K2ZP22292CZBGVM2ZS22Z262
Filed on: April 29, 2024
Form 6-K YS Biopharma Co., Ltd. For: Apr 29
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of April 2024
Commission file number: 001-41598
YS BIOPHARMA CO., LTD.
(Exact name of registrant as specified in its charter)
Building No. 2, 38 Yongda Road
Daxing Biomedical Industry Park
More SEC Filings
View Older Stories-
Form 424B5 UMB FINANCIAL CORP
-
Form DEFA14A GRAFTECH INTERNATIONAL
-
Form 497K JNL SERIES TRUST
-
Form 8-K Douglas Elliman Inc. For: Apr 26
-
Form 8-K Owens Corning For: Apr 29
-
Form 25-NSE John Hancock Tax-Advanta Filed by: NEW YORK STOCK EXCHANGE LLC
-
Form 10-K/A CalciMedica, Inc. For: Dec 31
-
Form 10-K/A Altisource Asset Managem For: Dec 31
-
Form ARS Vital Farms, Inc. For: Dec 31
-
Form 8-K CPS TECHNOLOGIES CORP/DE For: Apr 25
-
Form 8-K Scorpius Holdings, Inc. For: Apr 29
-
Form 6-K Valens Semiconductor For: Apr 29
-
Form 485BPOS DAVIS SERIES INC
-
Form 8-K OGLETHORPE POWER CORP For: Apr 29
-
Form 8-K ON SEMICONDUCTOR CORP For: Apr 29
-
Form 10-D World Omni Automobile For: Mar 31
-
Form ARS Carisma Therapeutics For: Dec 31
-
Form D/A Lantah Co
-
Form DEFA14A Vital Farms, Inc.
-
Form 20-F Tuniu Corp For: Dec 31
-
Form 8-K COLLEGIUM PHARMACEUTICAL For: Apr 26
-
Form DEFA14A C4 Therapeutics, Inc.
-
Form 425 UMB FINANCIAL CORP Filed by: UMB FINANCIAL CORP
-
Form 10-Q NEWMONT Corp /DE/ For: Mar 31
-
Form 497K JNL SERIES TRUST
-
Form 10-K Namliong SkyCosmos, Inc. For: Dec 31
-
Form 6-K DAQO NEW ENERGY CORP. For: Apr 29
-
Form DEF 14A C4 Therapeutics, Inc. For: Apr 29
-
Form ARS Compass Therapeutics, For: Dec 31
-
Form DEF 14A Carisma Therapeutics For: Jun 13
-
Form 497K T. Rowe Price Equity
-
Form 497 T. Rowe Price Equity
-
Form 425 California BanCorp Filed by: Southern California Bancorp \ CA
-
Form DEFA14A Compass Therapeutics,
-
Form 8-K California BanCorp For: Apr 29
-
Form 20-F SunCar Technology Group For: Dec 31
-
Form ARS NOVAVAX INC For: Dec 31
-
Form DEF 14A Vital Farms, Inc. For: Jun 12
-
Form 1-K Sugarfina Corp For: Dec 31
-
Form 8-K Southern California Banc For: Apr 29
-
Form 6-K Enlivex Therapeutics For: Apr 29
-
Form 424B2 ROYAL BANK OF CANADA
-
Form 8-K UMB FINANCIAL CORP For: Apr 28
-
Form NT 20-F First High-School Educat For: Dec 31
-
Form 8-K Auto Parts 4Less Group, For: Apr 29
-
Form 8-K Aclarion, Inc. For: Apr 26
-
Form 8-K ALLIANCE RESOURCE PARTNE For: Apr 29
-
Form 10-K/A CBAK Energy Technology, For: Dec 31
-
Form 8-K Innovative Eyewear Inc For: Apr 28
-
Form 8-K Mosaic ImmunoEngineering For: Apr 26